etoposide has been researched along with 9-deoxy-delta-9-prostaglandin d2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, SG; Jeong, SW; Kim, BE; Kim, HS; Kim, IK; Kim, JW; Lee, JH; Rhim, H; Shim, JY | 1 |
Suzuki, K; Uyeda, M | 1 |
2 other study(ies) available for etoposide and 9-deoxy-delta-9-prostaglandin d2
Article | Year |
---|---|
Sox-4 is a positive regulator of Hep3B and HepG2 cells' apoptosis induced by prostaglandin (PG)A(2) and delta(12)-PGJ(2).
Topics: Apoptosis; Blotting, Western; Calcimycin; Caspase 1; Caspase Inhibitors; Etoposide; Gene Expression Regulation, Neoplastic; High Mobility Group Proteins; Humans; Liver Neoplasms; Oligopeptides; Prostaglandin D2; Prostaglandins A; SOXC Transcription Factors; Trans-Activators; Transfection; Tumor Cells, Cultured | 2002 |
Inhibitory properties of antitumor prostaglandins against topoisomerases.
Topics: Animals; Antineoplastic Agents; Camptothecin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Superhelical; Doxorubicin; Enzyme Inhibitors; Ethidium; Etoposide; Humans; Mice; Prostaglandin D2; Prostaglandins; Prostaglandins A; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2002 |